Evidence map›Paper›PMID 40777781›Full record

ArticleFundamental research2025

Deep learning-assisted terahertz intelligent detection and identification of cancer tissue.

Xingyu Wang, Yafei Xu, Rong Wang, Nuoman Tian, Zhengpeng Zhu, Shuting Fan, Liuyang Zhang, Ruqiang Yan, Xuefeng Chen

Abstract read
In one paragraph

Article in Fundamental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xingyu WangState Key Laboratory for Manufacturing Systems Engineering, Xi'an Jiaotong University, Xi'an 710049, China.
Yafei XuZhengzhou Research Institute, Harbin Institute of Technology, Zhengzhou 450000, China.
Rong WangState Key Laboratory for Manufacturing Systems Engineering, Xi'an Jiaotong University, Xi'an 710049, China.
Nuoman TianState Key Laboratory for Manufacturing Systems Engineering, Xi'an Jiaotong University, Xi'an 710049, China.
Zhengpeng ZhuDepartment of Pathology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan 442008, China.
Shuting FanKey Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Physics and Optoelectronics Engineering, Shenzhen University, Shenzhen 518060, China.
Liuyang ZhangState Key Laboratory for Manufacturing Systems Engineering, Xi'an Jiaotong University, Xi'an 710049, China.
Ruqiang YanState Key Laboratory for Manufacturing Systems Engineering, Xi'an Jiaotong University, Xi'an 710049, China.
Xuefeng ChenState Key Laboratory for Manufacturing Systems Engineering, Xi'an Jiaotong University, Xi'an 710049, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer, as one of the most notorious health diseases, represents the main reason attributed to millions of worldwide deaths each year. Timely detection and accurate diagnosis are thus vital to cancer prevention and timely therapy. Traditional cancer prescreening is not only cumbersome but also heavily reliant on sufficient expert knowledge, which inevitably increases the complexity of cancer diagnosis and limits early cancer diagnosis. To overcome this problem, recent terahertz (THz) technology, as an unconventional bio-friendly detection approach, has emerged with great potential in human disease diagnosis due to its non-ionic and high-resolution features. By combining the THz detection technique and artificial intelligence technique, here we propose a dense and efficient channel attention network (DECANet) framework-based THz diagnosis system for cancer prescreening. The cancer identification and diagnosis process are transformed into one end-to-end classification process of THz signals reflected from cancer tissue. The biosamples of breast and skin cancer tissue are characterized to validate the effectiveness and applicability of the proposed approach. Our quantified results indicate that our proposed THz diagnosis framework has promising feature extraction capability for abnormal cancerous tissue and provides an effective complement tool to assist the healthcare cancer diagnosis.

Indexed as

Artificial intelligenceAutomatic and intelligent diagnosisCancer diagnosisTerahertz detection techniqueTerahertz time-domain spectroscopy

Identifiers

PMID40777781
PMCPMC12327867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.